Clinical Trial: A Study to Investigate the Pharmacokinetics of Tirabrutinib in Participants With Mild, Moderate, and Severe Hepatic Impairment Compared to Healthy Participants

U.S., Oct. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07198087) titled 'A Study to Investigate the Pharmacokinetics of Tirabrutinib in Participants With Mild, Moderate, and Severe Hepatic Impairment Compared to Healthy Participants' on Aug. 31.

Brief Summary: A study to investigate the pharmacokinetics of tirabrutinib in participants with mild, moderate, and severe hepatic impairment compared to healthy participants

Study Start Date: Jan. 04, 2026

Study Type: INTERVENTIONAL

Condition: Primary Central Nervous System Lymphoma (PCNSL)

Intervention: DRUG: Tirabrutinib

Administered orally

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Ono Pharmaceutical Co. Ltd

Published by HT Digital Content Servi...